DMAAR
Drugs Made In America Acquisition Corp Rights
DMAAR
DMAAR
32 hedge funds and large institutions have $3.07M invested in Drugs Made In America Acquisition Corp Rights in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$23.2K | |
| 2 | +$19.7K | |
| 3 | +$19.4K | |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$7.86K |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$4.85K |
Top Sellers
| 1 | -$23.2K | |
| 2 | -$19.1K | |
| 3 | -$10.7K | |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$9.98K |
| 5 |
CS
Clear Street
New York
|
-$6.53K |
